Swedish Orphan Biovitrum Returns to Profit in Q3, Updates FY26 Outlook
Swedish Orphan Biovitrum said it returned to profit in the third quarter of 2026 from a year-earlier loss, helped by higher revenue, especially in Haematology. The company also updated its annual revenue outlook.
STOCKHOLM (dpa-AFX) - Swedish Orphan Biovitrum AB (SWOBY, BIOVF, SOBI.ST) Tuesday said that it turned to a profit in the third quarter of 2026 from last year's loss, helped by higher revenues, especially from the Haematology division. Looking ahead, the company also updated its annual revenue outlo…